Martin has a PhD from the University of Cambridge, and moved to the University of California, Irvine for a postdoc. His research focus is the synthesis of complex molecules for commercial applications. Prior to joining Nuclera he worked for Chiroscience, Chirotech, Dow and Dr Reddy's.
Want to know more about our mission to change synthetic biology?
Our mission is simple: provide high-quality genes and proteins at your benchtop.